Endava plc
NYSE:DAVASoftware - Infrastructure
-$0.10 today
- Market cap
- $75.88M
- Beta
- 1.04
- P/E (TTM)
- -0.3
- EPS (TTM)
- -$7.98
Volume 0.27M
Average 0.34M
DAVA Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
Endava plcNYSE: DAVA
Research & Development · Q3 FY2026 · quarter ended Mar 2026
Research & development remains negative
Q3 FY2026 research & development was £0, compared with £0 a year earlier. Trailing-twelve-month research & development was £0.
Context
- Research & development amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
- Research & development increased in 0 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly research & development holds near £0 or moves back toward the trailing-twelve-month quarterly average of £0.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
GBP · from the income statement
- Latest · FY2025
- 0 GBP
- Year-over-year change
- —
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-06-30 | 0 | — |
| FY2024 | 2024-06-30 | 0 | — |
| FY2023 | 2023-06-30 | 0 | — |
| FY2022 | 2022-06-30 | 0 | — |
| FY2021 | 2021-06-30 | 0 | — |
Research & Development vs competitors
How DAVA compares with its peers on the latest reported figures
- Peers report in different currencies, so research & development is compared through growth and share of revenue rather than absolute size.
- Research & development amounts to 0.0% of revenue for DAVA, versus a peer median of 0.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $136.49M USD | +13.4% | +8.5% | 17.3% | |
| LTM Mar 2026 | $45.54M USD | +3.0% | +11.7% | 30.4% | |
| LTM Mar 2026 | $35.31M USD | +10.0% | -6.5% | 14.4% | |
| LTM Mar 2026 | $7.67M USD | +2.4% | -9.3% | 2.2% | |
| LTM Mar 2026 | £0 GBP | — | — | 0.0% | |
CLMBClimb Global Solutions, Inc. | LTM Mar 2026 | $0 USD | — | — | 0.0% |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| FY2025 | $0 USD | — | — | 0.0% | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| Peer median (excluding DAVA) | — | +6.5% | +1.0% | 0.0% | |
Competitors are the stored peer set for DAVA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Jun 2021 | FY2022 Jun 2022 | FY2023 Jun 2023 | FY2024 Jun 2024 | FY2025 Jun 2025 |
|---|---|---|---|---|---|
| Revenue | 446.3M | 654.76M | 794.73M | 740.76M | 772.26M |
| Cost of Revenue | 292.12M | 436.83M | 530.66M | 551.95M | 574.15M |
| Gross Profit | 154.18M | 217.93M | 264.08M | 188.81M | 198.1M |
| Gross Margin | 34.5% | 33.3% | 33.2% | 25.5% | 25.7% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 0 | 121.81M | 135.3M | 0 | 0 |
| Operating Expenses | 90.63M | 122.55M | 150.3M | 168.67M | 166.6M |
| Depreciation & Amortization | 12.3M | 17.8M | 21M | 25.29M | 30.42M |
| EBITDA | 79.19M | 113.56M | 142.38M | 59.57M | 67.46M |
| EBITDA Margin | 17.7% | 17.3% | 17.9% | 8.0% | 8.7% |
| Operating Income | 63.55M | 95.38M | 112.85M | 20.14M | 31.51M |
| Operating Margin | 14.2% | 14.6% | 14.2% | 2.7% | 4.1% |
| Interest Income | 104K | 249.87K | 3.9M | 6.19M | 1.26M |
| Interest Expense | 2.46M | 3.06M | 3.68M | 6.27M | 10.7M |
| Other Income / Expenses | (9.18M) | 7M | 1.32M | 6.84M | (7.39M) |
| Income Before Tax | 54.37M | 102.38M | 114.16M | 26.98M | 24.11M |
| Pre-Tax Margin | 12.2% | 15.6% | 14.4% | 3.6% | 3.1% |
| Income Tax Expense | 10.92M | 19.29M | 20M | 9.86M | 2.9M |
| Net Income | 43.45M | 83.09M | 94.16M | 17.12M | 21.21M |
| Net Margin | 9.7% | 12.7% | 11.8% | 2.3% | 2.7% |
| EPS (Basic) | 0.79 | 1.48 | 1.64 | 0.29 | 0.36 |
| EPS (Diluted) | 0.76 | 1.43 | 1.62 | 0.29 | 0.36 |
| Weighted Avg Shares | 55.22M | 56.27M | 57.31M | 58.44M | 58.46M |
| Weighted Avg Shares (Diluted) | 57.05M | 58.02M | 58.08M | 58.8M | 58.88M |
Endava plc
NYSE:DAVA
Intrinsic Alpha fair value
Locked
Current Price
$1.35
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.